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Extrinsic allergic alveolitis (EAA)' or hypersensitivity pneumonitis is caused by
exposure to allergens derived, forinstance, from pigeon and parakeets or from acti-
nomycetes found in moldy hay (1, 2) . Among the possible immunological mecha-
nisms involved in EAA, T cell-mediated reactions are discussed (3), but in general,
EAA is considered a type III immune complex disease (4, 5) . Immune complex de-
positsmay activatecomplement and initiate inflammation with recruitment ofgran-
ulocytes (6) . While deposition of immunoglobulin and of complement can be de-
tected in histology (7), there is, however, no consistent decrease of plasma complement
levels observed in patients with EAA (8) .
An involvement of an IgE response until recently appeared unlikely since prick
tests were found negative and no specific IgE was detectable in serum of patients
with EAA (4) . On the other hand, bird antigens in principle are able to induce an
IgE response as demonstrated in asthmatic bird fanciers (9). Based on a frequently
observed obstructive component similar to allergic asthma and the sometimes im-
mediate onset of clinical symptoms in EAA, we hypothesized that IgE might be in-
volved in EAA, but might be operative only locally in the bronchoalveolar space .
In fact, a role for IgE in EAA was suggested by studies demonstrating histamine
release from bronchoalveolar lavage cells after addition of anti-IgE (10) . Since IgE
antibodies are only effective when bound to specific Fc-receptors on the surface of
leukocytes, we investigated theexpression ofsuch FcR on alveolar macrophages (AM)
in patients with EAA. As demonstrated herein, there is a strong upregulation of
the Fc ERII in such patients . Furthermore, these FcRs appear to be partially occu-
pied by endogenous IgE, suggesting that IgE-mediated activation of alveolar mac-
rophages may be involved in pathophysiology of EAA.
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Materials and Methods
10 untreated patients with EAA (7 women, 3 men; mean age 43; range between 23 and
66 yr) were investigated. The diagnosis was based on a history of antigen exposure, typical
clinical features (dyspnea, cough, chills, weight loss, fever), diffuse opacities in chest x-ray,
and the functional pattern of interstitial lung disease. Pulmonary function tests included dy-
namic spirometry, flow volume spirometry, blood gas analysis, and single-breath diffusing
capacity (DLco). All patients had precipitating antibodies against the relevant antigens as
determined in Ouchterlony assays kindly provided by Dr. de Haller, Geneva, Switzerland.
Time between last antigen exposure and examination ranged between 1 and 4 d.
For comparison we investigated 10 patients with pulmonary sarcoidosis (5 men, 5 women;
mean age 29; range between 21 and 48). Diagnosis was confirmed by histological examina-
tion of transbronchial biopsies.
As controls 6 healthy volunteers (5 women, 1 man; mean age 26; range between 24 and
29 years) were examined. Clinical evaluation showed no pulmonary abnormalities. All pa-
tients and controls were nonsmokers.
After informed consent was obtained, all persons underwent fiberoptic bronchoscopy and
bronchoalveolar lavage (BAL). Lavage was performed by instillating 160 ml 0.9% saline solu-
tion in 20-ml aliquots into lingula or middle lobe and withdrawn by syringe. Total cells were
counted and cytocentrifuge smears were prepared for cytological and immunocytochemical
analysis. Differential counts of 100 cells were made (Wright-Giemsa staining). For immuno-
cytochemical staining mAbs were used in conjunction with the alkaline phosphatase anti-al-
kaline phosphatase (APAAP) technique (11). T cell subsets were identified with CD4' and
CD8' mAbs (Dakopatts, Hamburg, FRG). For identification of the Fcf-receptor (FcER) on
alveolar macrophages, the mAb M-L25 (CD23) (11) was used. In addition, the FcER was
identified with preformed IgE immune complexes consisting of a chimeric IgE with ahuman
IgE heavy chain and a murine NIP-specific variable region and of NIP (nitrophenyl-) ovalbu-
min as antigen. Binding of the complex was then detected with the murine anti-NIP mAb.
Endogenous IgE bound to the AM was detected with the mAb WE 567 (11). For all stainings
the IgG, CD8' mAb M-T8,, was used as isotype control. The slides were analyzed visually
by light microscopy and a total of 100 cellswere counted, in that for CD4/CD8 determination
only small cells (<10 lm) and for analysis IgE and IgE receptor expression only large cells
(>12 Am) were evaluated.
For cytometry images of 50-100 cells per specimen, we used a microscope (Zeiss Axiomat,
objective magnification x 25) and TV camera (Bosch TIVK9B1). Each cell was segmented
semiautomatically or interactively and was measured with an IBAS system (Kontron) inter-
faced to a Microvax computer (Digital Equipment) and the image analysis system BASISS
(12). The OD readings were corrected by substracting the background ofthe respective slide.
The OD values for all cells were allocated to one of 20 channels on a linear scale and distribu-
tions ofintensity versus cell number were plotted. Percent positive cells were determined using
channel-by-channel subtraction of isotype control histograms from histograms for specific
staining. Mean specific staining intensity was determined by substracting the mean OD for
the control staining from the mean OD for the specific M-L25 staining.
Results and Discussion
Five of the EAA patients studied were found to be reactive to thermophilic actino-
mycetes (Farmer's lung) and five to avian proteins (bird fancier's lung), as evidenced
by detection of specific IgG antibodies. The typical clinical symptoms such as fever
and dyspnea as well as impairment of lung function (P02 at rest <70 mm Hg, DL,.
<75%) were present in every patient. Bronchoalveolar lavage showed an increased
percentage of lymphocytes with predominance of CD8 + cells in most samples. Still,
with the increased recovery of BAL cells in EAA compared with control donors there
is a more than 10-fold increase in the number ofalveolar macrophages as well (Table I).PFORTE ET AL.
TABLE I
Cellular Composition of Bronchoalveolar Lavage
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Alveolar
Incubation of the BAL cells with the anti FcE-receptor antibody M-1,25 gave no
significant staining in controls andin patients with sarcoidosis. By contrast, astrong
staining of alveolar macrophages but not of lymphocytes was detected in EAA pa-
tients (Fig. 1), while the control antibody CD8+ stained only a portion of the lym-
phocytes but not the alveolar macrophages.
Microscopic inspection by eye revealed that an average of 73 % of alveolar macro-
phages were positive for FcE-receptor. In cytometry the evaluation of specific optical
densityusing digital image analysis demonstrates amonomodal distribution of stain-
ingintensity (Fig. 2). Determinationofthepercentage ofpositive cellslargelyconfirmed
the data from visual analysis in that an average of 71 .8% of AM was found to be
positive for M-1,25 in EAA, but no significant staining was seen in sarcoidosis or
in controls (Table II). Cytometry, however, revealed a lower percentage of positive
cellsin one case (Case 4), where an overlap ofcontrol staining and of specific stain-
ing rendered enumeration by eye difficult.
While specific optical density for M-L25 staining was between 0.05 and 0.15 for
the majority of EAA patients, one patient (Case 8, Table II) had an extremely high
valuewith a specific OD of0.265. This patient exhibited a more severe clinical course
with repeated attacks during the last years. At the time of bronchoscopy she had
fever andorthopnea. Chest x-rayshowed massive diffuse infiltrationsand lung func-
tion was strongly impaired in this patient. Basedon this observation, we may specu-
late that the degree of FceR expression correlates with the severity of clinical
symptoms.
Subjects Sex Age
Total
cell count
macro-
phages
Lympho-
cytes
Neutro-
phils
Eosino-
phils
T4/T8
ratio
x 106 % %
EAA 1 M 66 19.1 70 20 4 6 0.8
2 F 51 15.0 46 45 2 7 4 .0
3 M 35 12.7 40 16 17 25 0 .3
4 F 53 14.5 62 31 2 5 0.6
5 F 38 25.1 43 35 0 22 0 .4
6 F 57 19.5 29 61 1 9 0.6
7 F 49 12 .3 28 70 0 2 0.5
8 F 24 16.3 34 60 2 2 0.6
9 M 23 32 .0 46 48 1 5 0.3
10 F 39 28 .8 51 25 10 6 0.8
x±SD 7F,3M 43± 13 19±6 .5 45± 13 41 ± 17 4±5 9±7 0.9± 1.0
Sarcoiclosis
(n = 10)
x±SD 5F,5M 29± 10 8.2±2.0 73 ± 11 23±8 3±2 2 t 1 2 .1 ±0 .4
Controls
(n = 6)
x±SD 5F,1M 26±2 0.8±0.2 93±2 3± 1 3± 1 1 ± 1 ND1166
￿
Fc ERII, CD23 ON ALVEOLAR MACROPHAGES IN ALVEOLITIS
FIGURE 1 .
￿
FcE-receptor expression onAMs in exogenous allergic alveolitis . Cytospin prepara-
tions ofBAL cells from patient 9were stained with the anti-FcERII (CD23) mAb M-L25 (right)
and as isotype control with theCD8 mAbMT811 (left) . M-L25 strongly stains the (large) AM,
whileM-T811 recognizes part of the (small) lymphocytes, butno staining is observed in theAMs
with this reagent .
AM in EAA appear to be the major cells with upregulation of Fc ERII since no
significant staining of lymphoid cells in BAL was detected with M-L25 . Further-
more, this process appears to be restricted to the local site since in preliminary ex-
periments no staining of peripheral blood monocytes with M-L25 was detected in
EAA patients (data not shown) .
To confirm the results with the CD23 antibody, FcERs were also analyzed with
preformed IgE immune complexes . Results in patients 2, 6, 7, and in three addi-
FIGURE 2 .
￿
Evaluation of FcE-receptor expres-
sion by cytometry. The optical density of sam-
ples stained with the anti-FcERII (CD23) mAb
M-L25 or with theCD8 mAb MT811 was eval-
uated with a digital image analysis system by gat-
ingon the large (>12 wm) cells only. Cellswere
allocated to oneof20 channels on a linear scale .
Dark bars, M-L25 staining ; open bars, MT811
control staining . The percentage ofpositive AM
in this example was95%, themean specific stain-
ing intensity, i.e ., mean channel forM-L25minus
mean channel for MT811, was0.120 (patient 5) .PFORTE ET AL.
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TABLE 11
FceR Expression on AM in Exogenous Allergic Alveolitis
Fc,R (IgE-
x±SD
￿
73±6
￿
71 .8± 19 .2
￿
0.123±0 .053
￿
65±3 11 ￿66±6
Cells spun onto glass slides were reacted with the different mAbs antibodies and stained with APAAP tech-
nology. Both for visual evaluation and for cytometry only large (>12 Ftm) AMs were analyzed.
* IgE-anti-NIP, prefotmed immune complexes consisting ofa chimeric antibody with mouse anti-NIP binding
region and human IgE Fc-portion plus NIP albumin.
: Only cells with a circular staining were considered positive, while slight changes of diffuse granular stain-
ing were not evaluated.
4 AU, arbitrary units.
~~ Binding of IgE anti-NIP immune complexes was demonstrated in three additional EAA patients (x =
65 ± 6%).
Negative values in sarcoidosis and in controls result from the slightly higher background staining with the
CD8 control antibody compared with CD23 antibody .
tional patients (Table II and footnote) revealed strong circular staining ofthe AM
in EAA with again >60% positive cells, while in the apparently healthy controls
only a slightly increased diffuse granular staining was observed and no cells were
found positive (Table II, column 5).
Finally, we asked whetherbinding ofendogenous IgE to the Fc,R can be detected
on the AM ofEAA patients. In fact, staining with the anti-human IgE mAb M-E
567 demonstrated positivity in four EAA patients but not in control donors (Table
II, column 6). We do not know whether the IgE is allergen specific. This important
question would require sophisticated technology in order to discriminate specific
cell-bound IgE and specific cell-bound IgG. Ifit were specific IgE, we would have
to assume localproduction ofthisimmunoglobulin (13) inordertoexplainpreferen-
tial bindingofspecific over other IgE. Ourprominent finding, i.e., the strong stain-
ing with the CD23 antibody M-L25 on AM in 10 of 10 patients with EAA but not
in sarcoidosis or controls, would be consistent with an IgE-mediated process. Since
Subjects
FcfRII
Visualt
determination
(CD23)
Cytometric
Specific
Expression
determination
OD
anti-NIP)*
expression
Visual:
determination
Endogenous
IgE
Visual:
determination
% TO AU5 % %
EAA 1 71 59 .0 0.116
2 70 74.3 0.113 62 65
3 78 85.6 0.115
4 64 32 .8 0.050 59
5 77 91 .8 0.127
6 65 69.5 0.090 64
7 72 53 .7 0.096 69 68
8 81 92.6 0.265 75
9 68 70.5 0.151
10 83 87 .7 0.114
Sarcoidosis (n = 10)
x ± SD 0 1 ± 0 -0.006 ± 0.0111 ND 0 (n = 4)
Controls (n = 6)
x ± SD 0 0 -0.004 ± 0.0061 0 (n = 4) 0 (n = 6)1168
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IL-4, aTcell-derived cytokine, is a potent inducerofIgE production and of FcERII
expression on monocytes (14, 15), we may speculate that this cytokine is produced
after allergen exposure in EAA, followed by induction ofIgE and IgE receptors on
AM. The IgE receptor may be shed and function as regulatory IgE binding factor
(16), but more importantly, FcERII on the cell surface when loaded with IgE may
transducean activating signal after crosslinking by allergen (17). The activated AM
may thenproduce a host ofinflammatory mediators includingAA metabolites and
cytokines. This pathophysiological conceptforEAA, based onthe findingofincreased
FcfRs is, however, not likely to be the only mechanism and it may be speculated
that theimmunecomplex-mediated mechanisms and IgE-induced mechanisms may
operate in parallel.
In addition to providing a clue for the explanation ofpathophysiology in EAA,
the finding of an upregulated FcERII in EAA may be of diagnostic value in that
it may substantiate the allergic etiology of an ill-defined interstitial lung disease,
and furthermore, it may assist in monitoring the clinical course of EAA.
Summary
Expression ofthe Fc receptor for IgE (FccR) was analyzed on alveolar macrophages
(AM) in 10 patients with extrinsic allergic alveolitis (EAA) compared with 10 pa-
tients with sarcoidosis and to 6 apparently healthy controls. By using the anti-FcERII
mAb M-L25 in immunocytochemistry experiments, we found that >60% ofAM
in 10 of 10 patients with EAA were strongly positive, as evidenced byvisual analysis
in light microscopy and by cytometry. By contrast, no significant staining was de-
tected in sarcoidosis orincontrols witheither method. Similarresultswere obtained
when FcER were identified with preformed immune complexes consisting of NIP-
specific human/mouse chimeric IgE antibody plus NIP-ovalbumin. Furthermore,
>60% ofAM in patients with EAA stained positive for IgE, demonstrating that en-
dogenous IgE is bound to the AM.
Our data suggest that IgE antibodies bound to FcERII on AM may be involved
in pathophysiologyofextrinsicallergic alveolitis by activation ofthe AM afterbind-
ing of allergen to the cell surface IgE. Furthermore, with the clearcut pattern of
FcERII expression in extrinsic allergic alveolitis it may be possible to use CD23 an-
tibodies for differential diagnosis of inflammatory lung disease.
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